Psychological disorders in patients with pulmonary arteriaI hypertension (Data from the PEPPAH-Study)

T. Meltendorf (Hannover, Germany), K. Kahl (Hannover, Germany), H. Gall (Gießen, Germany), M. Richter (Gießen, Germany), J. Fuge (Hannover, Germany), M. Hoeper (Hannover, Germany), H. Ghofrani (Gießen, Germany, Germany), K. Olsson (Hannover, Germany)

Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Session: Epidemiology and treatment of pulmonary arterial hypertension
Session type: E-poster session
Number: 1472

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Meltendorf (Hannover, Germany), K. Kahl (Hannover, Germany), H. Gall (Gießen, Germany), M. Richter (Gießen, Germany), J. Fuge (Hannover, Germany), M. Hoeper (Hannover, Germany), H. Ghofrani (Gießen, Germany, Germany), K. Olsson (Hannover, Germany). Psychological disorders in patients with pulmonary arteriaI hypertension (Data from the PEPPAH-Study). 1472

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Item performance of the pulmonary arterial hypertension symptoms and impact (PAH-SYMPACT®) questionnaire: Results from the SYMPHONY study with macitentan
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016

Current epoprostenol use in patients with severe pulmonary hypertension (PH): Data from the French PH registry
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Comparison of activities of daily living in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
Year: 2016


Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014


Prevalence of OSAS in a cohort of 1112 patients hospitalized for hypertension exploration
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


The comorbid patients with arterial hypertension and chronic obstructive pulmonary disease: Assessment of diastolic wall strain
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014


Genetic predisposition to arterial hypertension in patients with OSA
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013

Idiopathic pulmonary arterial hypertension in the elderly: Data from the French registry
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011

Impact of systemic inflammation on frequency and severityof mental disorders in COPD patients (pts)
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020


Sleep related breathing-disorders in patients with pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015


HRQoL in adult patients with Eisenmenger syndrome (ES) compared to patients with primary pulmonary hypertension (PPH) or post-embolic pulmonary hypertension (PEPH)
Source: Eur Respir J 2002; 20: Suppl. 38, 455s
Year: 2002

Sleep related breathing disorders (SRDB) in pulmonary hypertension. Effect of therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 2s
Year: 2001

Responsiveness of cambridge pulmonary hypertension outcome review (CAMPHOR) scores and utility in pulmonary hypertension (PH) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 343s
Year: 2007

Differences in anxiety and depression according to gender in patients with chronic obstructive pulmonary disease submitted to a pulmonary rehabilitation program
Source: International Congress 2016 – Latest insights into pulmonary rehabilitation
Year: 2016

The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012


Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016